Cryptocurrency stockpiler Strategy might have an obstacle in its path to S&P 500 inclusion — in the form of an “elephant” currently residing in the S&P Small-Cap 600 index.

SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- A new securities class action lawsuit against CarMax, Inc. (NYSE: KMX) has expanded the alleged class period to now include investors who purchased or otherwise acquired CarMax securities between June 20, 2025 and November 5, 2025. The period has been lengthened to include the severe market reaction to CarMax's announcement that it fired CEO Bill Nash, news which drove the price of CarMax shares down as much as $9.48 (-23%) on November 6, 2025.

Funds Distributed to 12 Local Small Businesses Supporting Economic Growth and Resilience Funds Distributed to 12 Local Small Businesses Supporting Economic Growth and Resilience

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Western Alliance Bancorporation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

While Strategy's stock has fallen a lot more than bitcoin, since bitcoin peaked in early October, the correlation between the two has actually increased.

CUMMING, Ga., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its premier new home community in Cumming, Georgia, Northfield , has a limited number of move-in ready and quick move-in homes available now. The Toll Brothers Sales Center and model home are open daily for tours at 4905 Travers Lane in Cumming.

Blue Owl Capital (NYSE: OWL) offers a highly scalable, asset-light business model, earning steady fees by managing capital for institutional investors without bearing credit risk directly. OWL's revenue is anchored by permanent or long-dated vehicles, providing annuity-like stability and predictable income streams with little impact from short-term market events. The firm's $251 billion AUM spans private credit, GP strategic capital, and real assets, with management fees driving over $1 billion in recurring annual revenue.

Can BEN's rapid expansion through acquisitions and partnerships fuel its next wave of growth? Let us find out.

Verizon's new 100G optical ring for Monumental Sports strengthens venue connectivity and supports its digital transformation push.

Warren Buffett's Berkshire Hathaway (BRK/B) now has Alphabet (GOOGL) as its 10th biggest holding. The firm revealed in a recent filing that it added a $3.4 billion stake in the Mag 7 giant while trimming its Apple (AAPL) stake by over $10 billion.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

NEWTOWN, Pa. , Nov. 17, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating potential violations of the federal securities laws involving Netflix, Inc. (NASDAQ: NFLX), resulting from allegations of providing potentially misleading business information to the investing public.

CEO of Palo Alto Networks recognized for his visionary leadership in the strengthening of Europe's digital security infrastructure SANTA CLARA, Calif. , Nov. 17, 2025 /PRNewswire/ -- The American Council on Germany (ACG) has honored Nikesh Arora, Chairman and CEO of Palo Alto Networks (NASDAQ: PANW), with this year's John J.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company") is hosting its 2025 Investor Day today at the Nasdaq MarketSite in New York City. The event features presentations by leaders across the business and begins at 2:00pm ET.

HCA Healthcare, Inc. ( HCA ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 12:00 PM EST Company Participants Mike Marks - CFO & Executive VP Conference Call Participants Justin Lake - Wolfe Research, LLC Presentation Justin Lake Wolfe Research, LLC All right. Good afternoon, I guess, right?

DaVita Inc. ( DVA ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 11:20 AM EST Company Participants Joel Ackerman - CFO & Treasurer Conference Call Participants Justin Lake - Wolfe Research, LLC Presentation Justin Lake Wolfe Research, LLC All right. Good morning.

SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.

CP secures a new five-year pact with locomotive engineers, boosting labor stability and supporting reliable service across key Midwest routes.

SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA rejection letter.

Ibotta, Inc. faces operational headwinds, leading to a cautious outlook on the stock. IBTA's recent quarterly results showed a notable earnings per share beat, but revenues declined by about 15% year-over-year. Shares have dropped significantly over the past year, yet current operational challenges prevent a Buy recommendation for IBTA at this time.